{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:30:03Z","timestamp":1790188203897,"version":"4.1.0"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T00:00:00Z","timestamp":1599264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T00:00:00Z","timestamp":1599264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s00774-020-01149-3","type":"journal-article","created":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T18:03:22Z","timestamp":1599329002000},"page":"746-758","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Executive summary of clinical practice guide on fracture risk in lifestyle diseases"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9001-5609","authenticated-orcid":false,"given":"Ippei","family":"Kanazawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Uenishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Shiraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Hagino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeko","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshitsugu","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"from the Japan Osteoporosis Society Lifestyle diseases-related Fracture Risk Investigation Committee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,5]]},"reference":[{"key":"1149_CR1","unstructured":"Committee for Development Guidelines for Prevention and Treatment of Osteoporosis (chairman Orimo H) (2015) Japanese 2015 guidelines for prevention and treatment of osteoporosis. Life Science Publishing 2015 (in Japanese)"},{"key":"1149_CR2","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1007\/s00198-018-4650-2","volume":"29","author":"SL Ferrari","year":"2018","unstructured":"Ferrari SL, Abrahamsen B, Napoli N, Akesson K, Chandran M, Eastell R, El-Haji Fuleihan G, Josse R, Kendler DL, Kraenzlin M, Suzuki A, Pierroz DD, Schwartz AV, Leslie WD, Bone, and diabetes working group of IOF (2018) Diagnosis and management of bone fragility in diabetes: an emerging challenge. Osteoporos Int 29:2585\u20132596","journal-title":"Osteoporos Int"},{"key":"1149_CR3","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1007\/s00125-017-4283-6","volume":"60","author":"AV Schwartz","year":"2017","unstructured":"Schwartz AV (2017) Diabetes, bone and glucose-lowering agents: clinical outcomes. Diabetologia 60:1170\u20131179","journal-title":"Diabetologia"},{"key":"1149_CR4","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/jbmr.2862","volume":"31","author":"SM Kim","year":"2015","unstructured":"Kim SM, Long J, Montez-Rath M, Leonard M, Chertow GM (2015) Hip fracture in patients with non-dialysis-requiring chronic kidney disease. J Bone Miner Res 31:1803\u20131809","journal-title":"J Bone Miner Res"},{"key":"1149_CR5","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2147\/COPD.S79638","volume":"11","author":"D Inoue","year":"2016","unstructured":"Inoue D, Watanabe R, Okazaki R (2016) COPD and osteoporosis: links, risks, and treatment challenges. Int J COPD 11:637\u2013648","journal-title":"Int J COPD"},{"key":"1149_CR6","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1210\/me.2007-0259","volume":"21","author":"SC Manolagas","year":"2007","unstructured":"Manolagas SC, Almeida M (2007) Gone with the Wnts: beta-catenin, T-cell factor, forkhead box O, and oxidative stress in age-dependent diseases of bone, lipid, and glucose metabolism. Mol Endocrinol 21:2605\u20132614","journal-title":"Mol Endocrinol"},{"key":"1149_CR7","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.tem.2010.01.010","volume":"21","author":"SC Manolagas","year":"2010","unstructured":"Manolagas SC, Parfitt AM (2010) What old means to bone. Trends Endocrinol Metab 21:369\u2013374","journal-title":"Trends Endocrinol Metab"},{"key":"1149_CR8","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev.med.46.1.223","volume":"46","author":"M Brownlee","year":"1995","unstructured":"Brownlee M (1995) Advanced protein glycosylation in diabetes and aging. Annu Rev Med 46:223\u2013234","journal-title":"Annu Rev Med"},{"key":"1149_CR9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00198-009-1066-z","volume":"21","author":"M Saito","year":"2010","unstructured":"Saito M, Marumo K (2010) Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus. Osteoporos Int 21:195\u2013214","journal-title":"Osteoporos Int"},{"key":"1149_CR10","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1210\/en.2013-1818","volume":"155","author":"M Notsu","year":"2014","unstructured":"Notsu M, Yamaguchi T, Okazaki K, Tanaka K, Ogawa N, Kanazawa I, Sugimoto T (2014) Advanced glycation end product 3 (AGE3) suppresses the mineralization of mouse stromal ST2 cells and human mesenchymal stem cells by increasing TGF-\u03b2 expression and secretion. Endocrinology 155:2402\u20132410","journal-title":"Endocrinology"},{"key":"1149_CR11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.bbrc.2015.02.091","volume":"461","author":"K Tanaka","year":"2015","unstructured":"Tanaka K, Yamaguchi T, Kanazawa I, Sugimoto T (2015) Effects of high glucose and advanced glycation end products on the expressions of sclerostin and RANKL as well as apoptosis in osteocyte-like MLO-Y4-A2 cells. Biochem Biophys Res Commun 461:193\u2013199","journal-title":"Biochem Biophys Res Commun"},{"key":"1149_CR12","doi-asserted-by":"crossref","first-page":"E355","DOI":"10.1152\/ajpendo.00309.2015","volume":"310","author":"Z Li","year":"2016","unstructured":"Li Z, Li C, Zhou Y, Chen W, Luo G, Zhang Z, Wang H, Zhang Y, Xu D, Sheng P (2016) Advanced glycation end products biphasically modulate bone resorption in osteoclast-like cells. Am J Physiol Endocrinol Metab 310:E355\u2013366","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1149_CR13","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s00223-015-9985-5","volume":"97","author":"M Saito","year":"2015","unstructured":"Saito M, Marumo K (2015) Effects of collagen crosslinking on bone material properties in health and disease. Calcif Tissue Int 97:242\u2013261","journal-title":"Calcif Tissue Int"},{"key":"1149_CR14","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1007\/s00198-006-0087-0","volume":"17","author":"M Saito","year":"2006","unstructured":"Saito M, Fujii K, Soshi S, Tanaka T (2006) Reductions in degree of mineralization and enzymatic collagen cross-links and increases in glycation induced pentosidine in the femoral neck cortex in cases of femoral neck fracture. Osteoporos Int 17:986\u2013995","journal-title":"Osteoporos Int"},{"key":"1149_CR15","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00774-018-0948-6","volume":"37","author":"I Kanazawa","year":"2019","unstructured":"Kanazawa I, Takeno A, Tanaka KI, Yamane Y, Sugimoto T (2019) Osteoporosis and vertebral fracture are associated with deterioration of activities of daily living and quality of life in patients with type 2 diabetes mellitus. J Bone Miner Metab 37:503\u2013511","journal-title":"J Bone Miner Metab"},{"key":"1149_CR16","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1001\/archinte.164.13.1422","volume":"164","author":"T Almdal","year":"2004","unstructured":"Almdal T, Scharling H, Jensen JS, Vestergaad H (2004) The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up. Arch Intern Med 164:1422\u20131426","journal-title":"Arch Intern Med"},{"key":"1149_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00223-017-0324-x","volume":"102","author":"H Miyake","year":"2018","unstructured":"Miyake H, Kanazawa I, Sugimoto T (2018) Association of bone mineral density, bone turnover markers, and vertebral fractures with all-cause mortality in type 2 diabetes mellitus. Calcif Tissue Int 102:1\u201313","journal-title":"Calcif Tissue Int"},{"key":"1149_CR18","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00198-006-0253-4","volume":"18","author":"P Vestergaard","year":"2007","unstructured":"Vestergaard P (2007) Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes\u2014a meta-analysis. Osteoporos Int 18:427\u2013444","journal-title":"Osteoporos Int"},{"key":"1149_CR19","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/aje\/kwm106","volume":"166","author":"M Janghorbani","year":"2007","unstructured":"Janghorbani M, Van Dam RM, Willett WC, Hu FB (2007) Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol 166:495\u2013505","journal-title":"Am J Epidemiol"},{"key":"1149_CR20","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00264-016-3146-y","volume":"40","author":"J Wang","year":"2016","unstructured":"Wang J, You W, Jing Z, Wang R, Fu Z, Wang Y (2016) Increased risk of vertebral fracture in patients with diabetes: a meta-analysis of cohort studies. Int Orthop 40:1299\u20131307","journal-title":"Int Orthop"},{"key":"1149_CR21","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1359\/jbmr.081207","volume":"24","author":"M Yamamoto","year":"2009","unstructured":"Yamamoto M, Yamaguchi T, Yamauchi M, Kaji H, Sugimoto T (2009) Diabetic patients have an increased risk of vertebral fractures independent of BMD or diabetic complications. J Bone Miner Res 24:702\u2013709","journal-title":"J Bone Miner Res"},{"key":"1149_CR22","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1007\/s00198-006-0155-5","volume":"17","author":"M Saito","year":"2006","unstructured":"Saito M, Fujii K, Mori Y, Marumo K (2006) Role of collagen enzymatic and glycation induced cross-links as a determinant of bone quality in spontaneously diabetic WBN\/Kob rats. Osteoporos Int 17:1514\u20131523","journal-title":"Osteoporos Int"},{"key":"1149_CR23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/jbmr.1763","volume":"28","author":"JM Patsch","year":"2013","unstructured":"Patsch JM, Burghardt AJ, Yap SP, Baum T, Schwartz AV, Joseph GB, Link TM (2013) Increased cortical porosity in type 2 diabetic postmenopausal women with fragility fractures. J Bone Miner Res 28:313\u2013324","journal-title":"J Bone Miner Res"},{"key":"1149_CR24","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1007\/s00198-014-2704-7","volume":"24","author":"R Dhaliwal","year":"2014","unstructured":"Dhaliwal R, Cibula D, Ghosh C, Weinstock RS, Moses AM (2014) Bone quality assessment in type 2 diabetes mellitus. Osteoporos Int 24:1969\u20131973","journal-title":"Osteoporos Int"},{"key":"1149_CR25","doi-asserted-by":"crossref","first-page":"e0222571","DOI":"10.1371\/journal.pone.0222571","volume":"14","author":"M Yamamoto","year":"2019","unstructured":"Yamamoto M, Yamauchi M, Sugimoto T (2019) Prevalent vertebral fracture is dominantly associated with spinal microstructural deterioration rather than bone mineral density in patients with type 2 diabetes mellitus. PLoS ONE 14:e0222571","journal-title":"PLoS ONE"},{"key":"1149_CR26","doi-asserted-by":"crossref","first-page":"R137","DOI":"10.1530\/EJE-16-0652","volume":"176","author":"K Hygum","year":"2017","unstructured":"Hygum K, Starup-Linde J, Harslof T, Vestergaard P, Langdahl BL (2017) Mechanisms in endocrinology: diabetes mellitus, a state of low bone turnover: a systematic review and meta-analysis. Eur J Endocrinol 176:R137\u2013157","journal-title":"Eur J Endocrinol"},{"key":"1149_CR27","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.2337\/dc12-1188","volume":"36","author":"L Oei","year":"2013","unstructured":"Oei L, Zillikens MC, Dehghan A, Buitendijk GH, Castano-Betancourt MC, Estrada K, Stolk L, Oei EH, van Meurs JB, Janssen JA, Hofman A, van Leeuwen JP, Witteman JC, Pols HA, Uitterlinden AG, Klaver CC, Franco OH, Rivadeneira F (2013) High bone mineral density and fracture risk in type 2 diabetes as skeletal complications of inadequate glucose control: the rotterdam study. Diabetes Care 36:1619\u20131628","journal-title":"Diabetes Care"},{"key":"1149_CR28","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1002\/jbmr.2462","volume":"30","author":"CI Li","year":"2015","unstructured":"Li CI, Liu CS, Lin WY, Meng NH, Chen CC, Yang SY, Chen HJ, Lin CC, Li TC (2015) Glycated hemoglobin level and risk of hip fracture in older people with type 2 diabetes: a competing risk analysis of Taiwan diabetes cohort study. J Bone Miner Res 30:1338\u20131346","journal-title":"J Bone Miner Res"},{"key":"1149_CR29","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1007\/s00198-017-4021-4","volume":"28","author":"YC Hung","year":"2017","unstructured":"Hung YC, Lin CC, Chen HJ, Chang MP, Huang KC, Chen YH, Chen CC (2017) Severe hypoglycemia and hip fracture in patients with type 2 diabetes: a nationwide population-based cohort study. Osteoporos Int 28:2053\u20132060","journal-title":"Osteoporos Int"},{"key":"1149_CR30","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1210\/jc.2016-2569","volume":"101","author":"SR Majumdar","year":"2016","unstructured":"Majumdar SR, Leslie WD, Lix LM, Morin SN, Johansson H, Oden A, McCloskey EV, Kanis JA (2016) Longer duration of diabetes strongly impacts fracture risk assessment: the manitoba BMD cohort. J Clin Endocrinol Metab 101:4489\u20134496","journal-title":"J Clin Endocrinol Metab"},{"key":"1149_CR31","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1210\/jcem.86.1.7139","volume":"86","author":"AV Schwartz","year":"2001","unstructured":"Schwartz AV, Sellmeyer DE, Ensrud KE, Cauley JA, Tabor HK, Schreiner PJ, Jamal SA, Black DM, Cummings SR, Study of osteoporotic features research group (2001) Older women with diabetes have an increased risk of fracture: a prospective study. J Clin Endocrinol Metab 86:32\u201338","journal-title":"J Clin Endocrinol Metab"},{"key":"1149_CR32","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1503\/cmaj.080486","volume":"180","author":"YK Loke","year":"2009","unstructured":"Loke YK, Singh S, Furberg CD (2009) Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis. CMAJ 180:32\u201339","journal-title":"CMAJ"},{"key":"1149_CR33","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1210\/jc.2010-0980","volume":"96","author":"KM Thraikill","year":"2011","unstructured":"Thraikill KM, Jo CH, Cockrell GE, Moreau CS, Fowlkes JL (2011) Enhanced excretion of vitamin D binding protein in type 1 diabetes: a role in vitamin D deficiency? J Clin Endocrinol Metab 96:142\u2013149","journal-title":"J Clin Endocrinol Metab"},{"key":"1149_CR34","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1210\/jc.2011-2186","volume":"97","author":"A Garcia-Martin","year":"2012","unstructured":"Garcia-Martin A, Rozas-Moreno P, Reyes-Garcia R, Morales-Santana S, Garcia-Fontana B, Garcia-Salcedo JA, Munoz-Torres M (2012) Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 97:234\u2013241","journal-title":"J Clin Endocrinol Metab"},{"key":"1149_CR35","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1210\/jc.2011-2958","volume":"97","author":"L Gennari","year":"2012","unstructured":"Gennari L, Merlotti D, Valenti R, Ceccarelli E, Ruvio M, Pietrini MG, Capodarca C, Franci MB, Campagna MS, Calabro A, Cataldo D, Stolakis K, Dotta F, Nuti R (2012) Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes. J Clin Endocrinol Metab 97:1737\u20131744","journal-title":"J Clin Endocrinol Metab"},{"key":"1149_CR36","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1210\/jc.2013-2143","volume":"98","author":"M Yamamoto","year":"2013","unstructured":"Yamamoto M, Yamauchi M, Sugimoto T (2013) Elevated sclerostin levels are associated with vertebral fractures in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 98:4030\u20134037","journal-title":"J Clin Endocrinol Metab"},{"key":"1149_CR37","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/jbmr.3002","volume":"32","author":"M Wallander","year":"2017","unstructured":"Wallander M, Axelsson KF, Nilsson AG, Lundh D, Lorentzon M (2017) Type 2 diabetes and risk of hip fractures and non-skeletal fall injuries in the elderly: a study from the fractures and fall injuries in the elderly cohort (FRAILCO). J Bone Miner Res 32:449\u2013460","journal-title":"J Bone Miner Res"},{"key":"1149_CR38","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1210\/jc.2008-2187","volume":"94","author":"I Kanazawa","year":"2009","unstructured":"Kanazawa I, Yamaguchi T, Yamauchi M, Yamamoto M, Kurioka S, Yano S, Sugimoto T (2009) Adiponectin is associated with changes in bone markers during glycemic control in type 2 diabetes mellitus. J Clin Endocrinol Metab 94:3031\u20133037","journal-title":"J Clin Endocrinol Metab"},{"key":"1149_CR39","first-page":"2915","volume":"82","author":"R Okazaki","year":"1997","unstructured":"Okazaki R, Totsuka Y, Hamano K, Ajima M, Miura M, Hirota Y, Hata K, Fukumoto S, Matsumoto T (1997) Metabolic improvement of poorly controlled noninsulin-dependent diabetes mellitus decreases bone turnover. J Clin Endocrinol Metab 82:2915\u20132920","journal-title":"J Clin Endocrinol Metab"},{"key":"1149_CR40","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.2337\/dc11-2184","volume":"35","author":"AV Schwartz","year":"2012","unstructured":"Schwartz AV, Margolis KL, Sellmeyer DE, Vittinghoff E, Ambrosius WT, Bonds DE, Josse RG, Schnall AM, Simmons DL, Hue TF, Palermo L, Hamilton BP, Green JB, Atkinson HH, O\u2019Connor PJ, Force RW, Bauer DC (2012) Intensive glycemic control is not associated with fractures or falls in the ACOORD randomized trial. Diabetes Care 35:1525\u20131531","journal-title":"Diabetes Care"},{"key":"1149_CR41","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S2213-8587(17)30327-3","volume":"5","author":"K Ueki","year":"2017","unstructured":"Ueki K, Sasako T, Okazaki Y, Kato M, Okahata S, Katsuyama H, Haraguchi M, Morita A, Ohashi K, Hara K, Morise A, Izumi K, Ishizuka N, Ohashi Y, Noda M, Kadowaki T, J-DOIT3 study group (2017) Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomized controlled trial. Lancet Diabetes Endocrinol 5:951\u2013964","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1149_CR42","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/jbmr.556","volume":"27","author":"LM Giangregorio","year":"2012","unstructured":"Giangregorio LM, Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA (2012) FRAX underestimates fracture risk in patients with diabetes. J Bone Miner Res 27:301\u2013308","journal-title":"J Bone Miner Res"},{"key":"1149_CR43","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00223-010-9450-4","volume":"88","author":"P Vestergaard","year":"2011","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2011) Are antiresorptive drugs effective against fractures in patients with diabetes? Calcif Tissue Int 88:209\u2013214","journal-title":"Calcif Tissue Int"},{"key":"1149_CR44","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s00223-015-0071-9","volume":"98","author":"D Inoue","year":"2016","unstructured":"Inoue D, Muraoka R, Okazaki R, Nishizawa Y, Sugimoto T (2016) Efficacy and safety of risedronate in osteoporosis subjects with comorbid diabetes, hypertension, and\/or dyslipidemia: a post hoc analysis of phase III trials conducted in Japan. Calcif Tissue Int 98:114\u2013122","journal-title":"Calcif Tissue Int"},{"key":"1149_CR45","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1359\/jbmr.040211","volume":"19","author":"O Johnell","year":"2004","unstructured":"Johnell O, Kanis JA, Black DM, Balogh A, Poor G, Sarkar S, Zhou C, Pavo I (2004) Associations between baseline risk factors and vertebral fracture risk in the multiple outcomes of raloxifene evaluation (MORE) study. J Bone Miner Res 19:764\u2013772","journal-title":"J Bone Miner Res"},{"key":"1149_CR46","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1359\/jbmr.070904","volume":"23","author":"KE Ensrud","year":"2008","unstructured":"Ensrud KE, Stock JL, Barrett-Connor E, Grady D, Mosca L, Khaw KT, Zhao Q, Agnusdei D, Cauley JA (2008) Effects of raloxifene on fracture risk in postmenopausal women: the Raloxifene Use for the Heart Trial. J Bone Miner Res 23:112\u2013120","journal-title":"J Bone Miner Res"},{"key":"1149_CR47","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.bone.2016.06.017","volume":"91","author":"AV Schwartz","year":"2016","unstructured":"Schwartz AV, Pavo I, Alam J, Disch DP, Schuster D, Harris JM, Krege JH (2016) Teriparatide in patients with osteoporosis and type 2 diabetes. Bone 91:152\u2013158","journal-title":"Bone"},{"key":"1149_CR48","first-page":"453","volume":"39","author":"S Tanaka","year":"2018","unstructured":"Tanaka S, Mizutani H, Tsuruya E, Mochizuki Y, Kuge K, Okubo N (2018) Safety and efficacy of long-term denosumab treatment in Japanese patients with osteoporosis in daily clinical practice. Ther Res 39:453\u2013465","journal-title":"Ther Res"},{"key":"1149_CR49","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1681\/ASN.2005111194","volume":"17","author":"TL Nickolas","year":"2006","unstructured":"Nickolas TL, McMahon DJ, Shane E (2006) Relationship between moderate to severe kidney disease and hip fracture in the United States. J Am Soc Nephrol 17:3223\u20133232","journal-title":"J Am Soc Nephrol"},{"key":"1149_CR50","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1053\/j.ajkd.2006.11.045","volume":"49","author":"A Yajima","year":"2007","unstructured":"Yajima A, Inaba M, Tominaga Y, Ito A (2007) Minimodeling reduces the rate of cortical bone loss in patients with secondary hyperparathyroidism. Am J Kidney Dis 49:440\u2013451","journal-title":"Am J Kidney Dis"},{"key":"1149_CR51","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s00198-005-1903-7","volume":"16","author":"L Dukas","year":"2005","unstructured":"Dukas L, Schacht E, Stahelin HB (2005) In elderly men and women treated for osteoporosis a low creatinine clearance of <65 ml\/min is a risk factor for falls and fractures. Osteoporos Int 16:1683\u20131690","journal-title":"Osteoporos Int"},{"key":"1149_CR52","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1001\/archinte.167.2.133","volume":"167","author":"KE Ensrud","year":"2007","unstructured":"Ensrud KE, Lui LY, Taylor BC, Ishani A, Shlipak MG, Stone KL, Cauley JA, Jamal SA, Antoniucci DM, Cummings SR, Osteoporotic fractures research group (2007) Renal function and risk of hip and vertebral fractures in older women. Arch Intern Med 167:133\u2013139","journal-title":"Arch Intern Med"},{"key":"1149_CR53","doi-asserted-by":"crossref","first-page":"646","DOI":"10.2215\/CJN.06040614","volume":"10","author":"KL Naylor","year":"2015","unstructured":"Naylor KL, Garg AX, Zou G, Langsetmo L, Leslie WD, Fraser LA, Adachi JD, Morin S, Goltzman D, Lentle B, Jackson SA, Josse RG, Jamal SA (2015) Comparison of fracture risk prediction among individuals with reduced and normal kidney function. Clin J Am Soc Nephrol 10:646\u2013653","journal-title":"Clin J Am Soc Nephrol"},{"key":"1149_CR54","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1681\/ASN.2006050546","volume":"18","author":"LF Fried","year":"2007","unstructured":"Fried LF, Briggs ML, Shlipak MG, Seliger S, Kestenbaum B, Stehman-Breen C, Samak M, Siscovick D, Harris T, Cauley J, Newman AB, Robbins J (2007) Association of kidney function with incident hip fracture in older adults. J Am Soc Nephrol 18:282\u2013286","journal-title":"J Am Soc Nephrol"},{"key":"1149_CR55","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1111\/j.1532-5415.2008.01807.x","volume":"56","author":"AZ La Croix","year":"2008","unstructured":"La Croix AZ, Lees JS, Wu L, Cauley JA, Shlipak MG, Ott SM, Robbins J, Curb JD, Leboff M, Bauer DC, Jackson RD, Kooperberg CL, Cummings SR, Women\u2019s health intiative observational (2008) Cystatin-C renal function, and incidence of hip fracture in postmenopausal women. J Am Geriatr Soc 56:1434\u20131441","journal-title":"J Am Geriatr Soc"},{"key":"1149_CR56","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/ki.2013.547","volume":"86","author":"KL Naylor","year":"2014","unstructured":"Naylor KL, McArthur E, Lesilie WD, Fraser LA, Jamal SA, Cadarette SM, Pouget JG, Lok CE, Hodsman AB, Adachi JD, Garg AX (2014) The three-year incidence of fracture in chronic kidney disease. Kidney Int 86:810\u2013818","journal-title":"Kidney Int"},{"key":"1149_CR57","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1210\/jc.2010-0099","volume":"95","author":"H Kaji","year":"2010","unstructured":"Kaji H, Yamauchi M, Yamaguchi T, Shigematsu T, Sugimoto T (2010) Mild renal dysfunction is a risk factor for a decrease in bone mineral density and vertebral fractures in Japanese postmenopausal women. J Clin Endocrinol Metab 95:4635\u20134642","journal-title":"J Clin Endocrinol Metab"},{"key":"1149_CR58","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.2215\/CJN.09130912","volume":"8","author":"MJ Elliot","year":"2013","unstructured":"Elliot MJ, James MT, Quinn RR, Ravani P, Tonelli M, Palacios-Derflingher L, Tan Z, Manns BJ, Kline GA, Ronksley PE, Hemmelgarn BR (2013) Estimated GFR and fracture risk: a population-based study. Clin J Am Soc Nephrol 8:1367\u20131376","journal-title":"Clin J Am Soc Nephrol"},{"key":"1149_CR59","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2215\/CJN.12871211","volume":"7","author":"RH Yenchek","year":"2012","unstructured":"Yenchek RH, Ix JH, Shlipak MG, Bauer DC, Rianon NJ, Kritchevsky SB, Harris TB, Newman AB, Cauley JA, Fried LF, Health, aging, and body composition study (2012) Bone mineral density and fracture risk in older individuals with CKD. Clin J Am Soc Nephrol 7:1130\u20131136","journal-title":"Clin J Am Soc Nephrol"},{"key":"1149_CR60","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/jbmr.2406","volume":"30","author":"SL West","year":"2015","unstructured":"West SL, Lok CE, Langsetmo L, Cheung AM, Szabo E, Pearce D, Fusaro M, Wald R, Weinstein J, Jamal SA (2015) Bone mineral density predicts fractures in chronic kidney disease. J Bone Miner Res 30:913\u2013919","journal-title":"J Bone Miner Res"},{"key":"1149_CR61","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/ndt\/gfr317","volume":"27","author":"S Iimori","year":"2012","unstructured":"Iimori S, MoriY AW, Kuyama T, Takada S, Asai T, Kuwahara M, Sasaki S, Tsukamoto Y (2012) Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients: a single-center cohort study. Nephrol Dial Transplant 27:345\u2013351","journal-title":"Nephrol Dial Transplant"},{"key":"1149_CR62","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s00774-018-0913-4","volume":"37","author":"M Kurajoh","year":"2019","unstructured":"Kurajoh M, Inaba M, Nagata Y, Yamada S, Imanishi Y, Emoto M (2019) Association of cystatin C- and creatinine-based eGFR with osteoporotic fracture in Japanese postmenopausal women with osteoporosis: sarcopenia as risk for fracture. J Bone Miner Metab 37:282\u2013291","journal-title":"J Bone Miner Metab"},{"key":"1149_CR63","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.2215\/CJN.00800209","volume":"4","author":"MF Moen","year":"2009","unstructured":"Moen MF, Zhan M, Hsu VD, Walker LD, Einhorn LM, Seliger SL, Fink JC (2009) Frequency of hypoglycemia and its significance in chronic kidney disease. Clin J Am Soc Nephrol 4:1121\u20131127","journal-title":"Clin J Am Soc Nephrol"},{"key":"1149_CR64","first-page":"1","volume":"7","author":"K Disease","year":"2011","unstructured":"Disease K (2011) Improving global outcomes (KDIGO) CKD-MBD update work group (2017) KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl 7:1\u201359","journal-title":"Kidney Int Suppl"},{"key":"1149_CR65","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000276666","volume":"29","author":"R Amerling","year":"2010","unstructured":"Amerling R, Harbord NB, Pullman J, Eeinfeld DA (2010) Bisphosphonate use in chronic kidney disease: association with adynamic bone disease in a bone histology series. Blood Purif 29:293\u2013299","journal-title":"Blood Purif"},{"key":"1149_CR66","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00198-018-4688-1","volume":"30","author":"D Miyaoka","year":"2019","unstructured":"Miyaoka D, Imanishi Y, Ohara M, Hayashi N, Nagata Y, Yamada S, Mori K, Emoto M, Inaba M (2019) Impaired residual renal function predicts denosumab-induced serum calcium decrement as well as increment of bone mineral density in non-severe renal insufficiency. Osteoporos Int 30:241\u2013249","journal-title":"Osteoporos Int"},{"key":"1149_CR67","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.bone.2012.02.639","volume":"50","author":"EM Dennison","year":"2012","unstructured":"Dennison EM, Compston JE, Flahive J, Siris ES, Gehlbach SH, Adachi JD, Boonen S, Chapurlat R, Diez-Perez A, Anderson FA Jr, Hooven FH, LaCroix AZ, Lindsay R, Netelenbos JC, Pfeilschifter J, Rossini M, Roux C, Saag KG, Sambrook P, Silverman S, Watts NB, Greenspan SL, Premaor M, Cooper C, Investigators GLOW (2012) Effect of co-morbidities on fracture risk: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW). Bone 50:1288\u20131293","journal-title":"Bone"},{"key":"1149_CR68","doi-asserted-by":"crossref","first-page":"e3427","DOI":"10.1136\/bmj.e3427","volume":"344","author":"J Hippisley-Cox","year":"2012","unstructured":"Hippisley-Cox J, Coupland C (2012) Derivation and validation of updated QFracture algorithm to predict risk of osteoporosis in primary care in the United Kingdom: prospective open cohort study. BMJ 344:e3427","journal-title":"BMJ"},{"key":"1149_CR69","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1183\/09031936.05.00058204","volume":"25","author":"F de Vries","year":"2005","unstructured":"de Vries F, van Staa TP, Bracke MS, Cooper C, Leufkens HG, Lammers JW (2005) Severity of obstructive airway disease and risk of osteoporotic fracture. Eur Respir J 25:879\u2013884","journal-title":"Eur Respir J"},{"key":"1149_CR70","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1378\/chest.07-1092","volume":"132","author":"P Vestergaard","year":"2007","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2007) Fracture risk in patients with chronic lung diseases treated with bronchodilator drugs and inhaled and oral corticosteroids. Chest 132:1599\u20131607","journal-title":"Chest"},{"key":"1149_CR71","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1183\/09031936.50130408","volume":"34","author":"L Graat-Verboom","year":"2009","unstructured":"Graat-Verboom L, Wouters EF, Smeenk FW, van den Borme BE, Lunde R, Spruit MA (2009) Current status of research on osteoporosis in COPD: a systematic review. Eur Respir J 34:209\u2013218","journal-title":"Eur Respir J"},{"key":"1149_CR72","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2147\/COPD.S79638","volume":"11","author":"D Inoue","year":"2016","unstructured":"Inoue D, Watanabe R, Okazaki R (2016) COPD and osteoporosis: links, risks, and treatment challenges. Int J Chron Obstruct Pulmon Dis 11:637\u2013648","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"1149_CR73","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s00774-014-0605-7","volume":"33","author":"R Watanabe","year":"2015","unstructured":"Watanabe R, Tanaka T, Aita K, Hagiya M, Homma T, Yokosuka K, Yamakawa H, Yarita T, Tai N, Hirano J, Inoue D, Okazaki R (2015) Osteoporosis is highly prevalent in Japanese males with chronic obstructive pulmonary disease and is associated with deteriorated pulmonary function. J Bone Miner Metab 33:392\u2013400","journal-title":"J Bone Miner Metab"},{"key":"1149_CR74","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1164\/ajrccm.157.3.9703080","volume":"157","author":"CE McEvoy","year":"1998","unstructured":"McEvoy CE, Ensrud KE, Bender E, Genant HK, Yu W, Griffith JM, Niewoehner DE (1998) Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157:704\u2013709","journal-title":"Am J Respir Crit Care Med"},{"key":"1149_CR75","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00198-017-4337-0","volume":"29","author":"R Watanabe","year":"2018","unstructured":"Watanabe R, Shiraki M, Saito M, Okazaki R, Inoue D (2018) Restrictive pulmonary dysfunction is associated with vertebral fractures and bone loss in elderly postmenopausal women. Osteoposos Int 29:625\u2013633","journal-title":"Osteoposos Int"},{"key":"1149_CR76","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/jbmr.257","volume":"26","author":"L Graat-Verboom","year":"2011","unstructured":"Graat-Verboom L, van den Borne BE, Smeenk FW, Spruit MA, Wouters EF (2011) Osteoporosis in COPD outpatients based on bone mineral density and vertebral fractures. J Bone Miner Res 26:561\u2013568","journal-title":"J Bone Miner Res"},{"key":"1149_CR77","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1002\/jbmr.88","volume":"25","author":"CA Kulak","year":"2010","unstructured":"Kulak CA, Borba VC, Jorgetti V, Dos Reis LM, Liu XS, Kimmel DB, Kulak J Jr, Rabelo LM, Zhou H, Guo XE, Bilezikian JP, Boguszewski CL, Dempster DW (2010) Skeletal microstructural abnormalities in postmenopausal women with chronic obstructive pulmonary disease. J Bone Miner Res 25:1931\u20131940","journal-title":"J Bone Miner Res"},{"key":"1149_CR78","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00198-017-4314-7","volume":"29","author":"R Watanabe","year":"2018","unstructured":"Watanabe R, Tai N, Hirano J, Ban Y, Inoue D, Okazaki R (2018) Independent association of bone mineral density and trabecular bone score to vertebral fracture in male subjects with chronic obstructive pulmonary disease. Osteoporos Int 29:615\u2013623","journal-title":"Osteoporos Int"},{"key":"1149_CR79","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.numecd.2008.12.006","volume":"19","author":"FL Fimognari","year":"2009","unstructured":"Fimognari FL, Loffredo L, Di Simone S, Sampietro F, Pastorelli R, Monald M, Violi F, D\u2019Angelo A (2009) Hyperhomocysteinaemia and poor vitamin B status in chronic obstructive pulmonary disease. Nutr Metab Cardiovasc Dis 19:654\u2013659","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"1149_CR80","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/thx.2011.160028","volume":"66","author":"YK Loke","year":"2011","unstructured":"Loke YK, Cavallazzi R, Singh S (2011) Risk of fractures with inhaled corticosteroids in COPD: systematic review and meta-analysis of randomised controlled trials and observational studies. Thorax 66:699\u2013708","journal-title":"Thorax"},{"key":"1149_CR81","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00198-016-3732-2","volume":"28","author":"PC Lu","year":"2017","unstructured":"Lu PC, Yang YH, Guo SE, Yang TM (2017) Factors associated with osteoporosis in patients with chronic obstructive pulmonary disease-a nationwide retrospective study. Osteoporos Int 28:359\u2013367","journal-title":"Osteoporos Int"},{"key":"1149_CR82","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1440-1843.2012.02265.x","volume":"18","author":"AG Mathioudakis","year":"2013","unstructured":"Mathioudakis AG, Amanetopoulou SG, Gialmanidis IP, Chatzimavridou-Grigoriadou V, Siasos G, Evangelopoulou E, Mathioudakis GA (2013) Impact of long-term treatment with low-dose inhaled corticosteroids on the bone mineral density of chronic obstructive pulmonary disease patients: aggravating or beneficial? Respirology 18:147\u2013153","journal-title":"Respirology"},{"key":"1149_CR83","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1378\/chest.127.6.1960","volume":"127","author":"TC Mineo","year":"2005","unstructured":"Mineo TC, Ambrogi V, Mineo D, Fabbri A, Fabbrini E, Massoud R (2005) Bone mineral density improvement after lung volume reduction surgery for severe emphysema. Chest 127:1960\u20131966","journal-title":"Chest"},{"key":"1149_CR84","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00198-015-3290-z","volume":"27","author":"MH Thorin","year":"2016","unstructured":"Thorin MH, Wihlborg A, Akesson K, Gerdhem P (2016) Smoking, smoking cessation, and fracture risk in elderly women followed for 10 years. Osteoporos Int 27:249\u2013255","journal-title":"Osteoporos Int"},{"key":"1149_CR85","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.injury.2015.04.008","volume":"46","author":"GS Shen","year":"2015","unstructured":"Shen GS, Li Y, Zhao G, Zhou HB, Xie ZG, Xu W, Chen HN, Dong QR, Xu YJ (2015) Cigarette smoking and risk of hip fracture in women: a meta-analysis of prospective cohort studies. Injury 46:1333\u20131340","journal-title":"Injury"},{"key":"1149_CR86","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s11914-018-0469-1","volume":"16","author":"M Saito","year":"2018","unstructured":"Saito M, Marumo K (2018) The effect of homocysteine on skeleton. Curr Osteoporos Rep 16:554\u2013560","journal-title":"Curr Osteoporos Rep"},{"key":"1149_CR87","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.bone.2015.09.006","volume":"81","author":"M Saito","year":"2015","unstructured":"Saito M, Kida Y, Nishizawa T, Arakawa S, Okabe H, Seki A, Marumo K (2015) Effects of 18-month treatment with bazedoxifene on enzymatic immature and mature cross-links and non-enzymatic advanced glycation end products, mineralization, and trabecular microarchitecture of vertebra in ovariectomized monkeys. Bone 81:573\u2013580","journal-title":"Bone"},{"key":"1149_CR88","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00198-016-3812-3","volume":"28","author":"S Kimura","year":"2017","unstructured":"Kimura S, Saito M, Kida Y, Seki A, Isaka Y, Marumo K (2017) Effects of raloxifene and alendronate on non-enzymatic collagen cross-links and bone strength in ovariectomized rabbits in sequential treatments after daily human parathyroid hormone (1\u201334) administration. Osteoporos Int 28:1109\u20131119","journal-title":"Osteoporos Int"},{"key":"1149_CR89","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00198-009-0980-4","volume":"21","author":"M Saito","year":"2010","unstructured":"Saito M, Marumo K, Soshi S, Kida Y, Ushiku C, Shinohara A (2010) Raloxifene ameliorates detrimental enzymatic and nonenzymatic collagen cross-links and bone strength in rabbits with hyperhomocysteinemia. Osteoporos Int 21:655\u2013666","journal-title":"Osteoporos Int"},{"key":"1149_CR90","first-page":"214","volume":"85","author":"BW Walsh","year":"2000","unstructured":"Walsh BW, Paul S, Wild RA, Dean RA, Tracy RP, Cox DA, Anderson PW (2000) The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled trial. J Clin Endocrinol Metab 85:214\u2013218","journal-title":"J Clin Endocrinol Metab"},{"key":"1149_CR91","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1067\/mob.2001.111065","volume":"184","author":"V De Leo","year":"2001","unstructured":"De Leo V, la Marca A, Morgante G, Lanzetta D, Setacci C, Petraglia F (2001) Randomized control study of the effects of raloxifene on serum lipids and homocysteine in older women. Am J Obstet Gynecol 184:350\u2013353","journal-title":"Am J Obstet Gynecol"},{"key":"1149_CR92","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s00223-016-0211-x","volume":"100","author":"I Kanazawa","year":"2017","unstructured":"Kanazawa I, Tomita T, Miyazaki S, Ozawa E, Yamamoto LA, Sugimoto T (2017) Bazedoxifene ameliorates homocysteine-induced apoptosis and accumulation of advanced glycation end products by reducing oxidative stress in MC3T3-E1 cells. Calcif Tissue Int 100:286\u2013297","journal-title":"Calcif Tissue Int"},{"key":"1149_CR93","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s00198-008-0585-3","volume":"19","author":"m Saito","year":"2008","unstructured":"Saito m, Mori S, Mashiba T, Komatsubara S, Marumo K (2008) Collagen maturity, glycation induced-pentosidine, and mineralization are increased following 3-year treatment with incadronate in dogs. Osteoporos Int 19:1343\u20131354","journal-title":"Osteoporos Int"},{"key":"1149_CR94","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.bone.2017.01.008","volume":"97","author":"T Mashiba","year":"2017","unstructured":"Mashiba T, Saito M, Tanaka YY, M, Iwata K, Yamamoto T, (2017) Effects of suppressed bone remodeling by minodronic acid and alendronate on bone mass, microdamage accumulation, collagen crosslinks and bone mechanical properties in the lumbar vertebra of ovariectomized cynomolgus monkeys. Bone 97:184\u2013191","journal-title":"Bone"},{"key":"1149_CR95","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s12020-018-1548-x","volume":"60","author":"P Anagnostis","year":"2018","unstructured":"Anagnostis P, Paschou SA, Gkekas NN, Artzouchaltzi AM, Christou K, Stogiannou D, Vryonidou A, Potoupnis M, Goulis DG (2018) Efficacy of anti-osteoporotic medications in patients with type 1 and 2 diabetes mellitus: a systematic review. Endocrine 60:373\u2013383","journal-title":"Endocrine"},{"key":"1149_CR96","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00223-016-0177-8","volume":"100","author":"AV Schwartz","year":"2017","unstructured":"Schwartz AV (2017) Efficacy of osteoporosis therapies in diabetic patients. Calcif Tissue Int 100:165\u2013173","journal-title":"Calcif Tissue Int"},{"key":"1149_CR97","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s00223-015-0071-9","volume":"98","author":"D Inoue","year":"2016","unstructured":"Inoue D, Muraoka R, Okazaki R, Nishizawa Y (2016) Sugimoto T (2016) Efficacy and safety of risedronate in osteoporosis subjects with comorbid diabetes, hypertension, and\/or dyslipidemia: a post hoc analysis of phase III trials conducted in Japan. Calcif Tissue Int 98:114\u2013122","journal-title":"Calcif Tissue Int"},{"key":"1149_CR98","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s00774-010-0191-2","volume":"29","author":"M Shiraki","year":"2011","unstructured":"Shiraki M, Kuroda T, Shiraki Y, Tanaka S, Higuchi T, Saito M (2011) Urinary pentosidine and plasma homocysteine levels at baseline predict future fractures in osteoporosis patients under bisphosphonate treatment. J Bone Miner Metab 29:62\u201370","journal-title":"J Bone Miner Metab"},{"key":"1149_CR99","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.bbrc.2008.10.036","volume":"377","author":"H Nagaoka","year":"2008","unstructured":"Nagaoka H, Mochida Y, Atsawasuwan P, Kaku M, Kondoh T, Yamaguchi M (2008) 1,25(OH)2D3 regulates collagen quality in an osteoblastic cell culture system. Biochem Biophys Res Commun 377:674\u2013678","journal-title":"Biochem Biophys Res Commun"},{"key":"1149_CR100","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.bone.2009.12.008","volume":"46","author":"M Saito","year":"2010","unstructured":"Saito M, Shiraishi A, Ito M, Sakai S, Hayakawa N, Mihara M, Marumo K (2010) Comparison of effects of alfacalcidol and alendronate on mechanical properties and bone collagen cross-links of callus in the fracture repair rat model. Bone 46:1170\u20131179","journal-title":"Bone"},{"key":"1149_CR101","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bone.2014.11.025","volume":"73","author":"M Saito","year":"2015","unstructured":"Saito M, Grynpas MD, Burr DB, Allen MR, Smith SY, Doyle N, Amizuka N, Hasegawa T, Kida Y, Marumo K, Saito H (2015) Treatment with eldecalcitol positively affects mineralization, microdamage, and collagen crosslinks in primate bone. Bone 73:8\u201315","journal-title":"Bone"},{"key":"1149_CR102","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1007\/s00198-010-1454-4","volume":"22","author":"M Saito","year":"2011","unstructured":"Saito M, Marumo K, Kida Y, Ushiku C, Kato S, Takao-Kawabata R, Kuroda T (2011) Changes in the contents of enzymatic immature, mature, and no-enzymatic senescent cross-links of collagen after once-weekly treatment with human parathyroid hormone (1\u201334) for 18 months contribute to improvement of bone strength in ovariectomized monkeys. Osteoporos Int 22:2373\u20132383","journal-title":"Osteoporos Int"},{"key":"1149_CR103","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s00223-018-0500-7","volume":"104","author":"S Yoshitake","year":"2019","unstructured":"Yoshitake S, Mashiba T, Saito M, Fujihara R, Iwata K, Takao-Kawabata R, Yamamoto T (2019) Once-weekly teriparatide treatment prevents microdamage accumulation in the lumbar vertebral trabecular bone of ovariectomized cynomolgus monkeys. Calcif Tissue Int 104:402\u2013410","journal-title":"Calcif Tissue Int"},{"key":"1149_CR104","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","volume":"377","author":"KG Saag","year":"2017","unstructured":"Saag KG, Petersen J, Brandi ML, Karaplis AC, Lorentzon M, Thomas T, Maddox J, Fan M, Meisner PD, Grauer A (2017) Romosozumab or alendronate for fracture prevention in women with osteoporosis. N Engl J Med 377:1417\u20131427","journal-title":"N Engl J Med"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-020-01149-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00774-020-01149-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-020-01149-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T23:26:16Z","timestamp":1630797976000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00774-020-01149-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,5]]},"references-count":104,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["1149"],"URL":"https:\/\/doi.org\/10.1007\/s00774-020-01149-3","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,5]]},"assertion":[{"value":"2 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"IK has received research grants from MSD, Teijin pharma, and Novartis. MI has received research grants from Chugai Pharmaceutical, Kyowa-Kirin Co, Asahi Kasei Pharma, Ono Pharmaceutical, Novartis Pharma, Bayer Pharmaceutical, Roche DC Japan, Sumitomo Dainippon Pharma, Teijin Pharma, Takeda Pharmaceutical, and lecture and\/or consulting fees from Chugai Pharmaceutical, Pfizer Inc, Bayer Pharmaceutical, Kyowa-Kirin Co, Kissei, Torii Pharmaceutical, Daiichi-Sankyo, and Ono Pharmaceutical. DI has received lecture and\/or consulting fees from EA Pharma, Astellas Pharma, Asahi Kasei Pharma, Chugai Pharmaceutical, Daiichi-Sankyo Co., Ono Pharmaceutical and Teijin Pharma. MS has received research grants from Chugai Pharmaceutical Asahi Kasei Pharma and lecture fees from Chugai Pharmaceutical Astellas Amgen Biopharma Pfizer Inc Eli Lilly Daiichi-Sankyo Taisho Pharma Teijin Pharma and Asahi Kasei Pharma. MS has received consultant fee from Teijin pharma Co., Asahi Kasei Pharma Co, Daiichi-Sankyo. AS has received research grants from Kowa, Ono Pharmaceutical, Taisho Pharmaceutical, Chugai Pharmaceutical and Takeda Pharmaceutical, as well as lecture and\/or consulting fees from Asahi Kasei Pharma, Astellas Pharma, Daiichi-Sankyo, Kyowa Kirin, Taisho Pharmaceutical, Chugai Pharmaceutical and Eli Lilly Japan. YT has received personal fees from Chugai, Daiichi-Sankyo, Teijin Pharma, Asahi Kasei Pharma and Kyowa Kirin. HH has received grants\/research support or lecture fees from Asahi Kasei Pharma, Astellas Pharma, Chugai, Daiichi-Sankyo, Eisai, Eli Lilly Japan, Mitsubishi Tanabe, Merck Sharp & Dohme, Mochida, Ono, Pfizer, Taisho Toyama Pharmaceutical, and Teijin Pharma. SF has received lecture fees from Teijin, Nippon-Zoki, and Astellas Amgen Japan. TS has received research grants from Astellas Pharma, Eisai, Daiichi-Sankyo, Chugai Pharmaceutical and Eli Lilly Japan, as well as lecture and\/or consulting fees from Asahi Kasei Pharma and Daiichi-Sankyo.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}